Total Payments
$382.05
2024 Payments
$257.72
Companies
6
Transactions
17
Medicare Patients
468
Medicare Billing
$16,389
Payment Breakdown by Category
Food & Beverage$382.05 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $382.05 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $126.25 | 5 | $0 (2024) |
| Exact Sciences Corporation | $112.58 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $48.32 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $39.57 | 2 | $0 (2024) |
| Novo Nordisk Inc | $33.79 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $21.54 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $257.72 | 12 | ABBVIE INC. ($126.25) |
| 2023 | $124.33 | 5 | Exact Sciences Corporation ($86.73) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Biological | ||||||
| 05/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Oncology | ||||||
| 04/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Obesity | ||||||
| 12/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Oncology | ||||||
| 08/02/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Biological | ||||||
| 07/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Oncology | ||||||
| 04/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 04/14/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 452 | 635 | $58,296 | $14,529 |
| 2022 | 1 | 16 | 26 | $8,127 | $1,860 |
Total Patients
468
Total Services
661
Medicare Billing
$16,389
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 82 | $22,265 | $3,426 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 46 | $17,500 | $3,151 | 18.0% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 18 | 24 | $1,488 | $657.12 | 44.2% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 26 | 37 | $1,406 | $614.20 | 43.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 18 | 24 | $1,128 | $606.96 | 53.8% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 18 | 24 | $1,152 | $599.04 | 52.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 26 | 35 | $1,365 | $576.10 | 42.2% |
| 82627 | Dehydroepiandrosterone (dhea-s) hormone level | Office | 2023 | 18 | 24 | $1,224 | $522.96 | 42.7% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 18 | 24 | $1,152 | $511.20 | 44.4% |
| 84144 | Progesterone (reproductive hormone) level | Office | 2023 | 18 | 24 | $1,152 | $490.56 | 42.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 26 | 32 | $1,376 | $472.96 | 34.4% |
| 82533 | Cortisol (hormone) measurement, total | Office | 2023 | 22 | 29 | $1,218 | $463.13 | 38.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 30 | 45 | $675.00 | $378.00 | 56.0% |
| 83001 | Gonadotropin, follicle stimulating (reproductive hormone) level | Office | 2023 | 15 | 20 | $840.00 | $364.20 | 43.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 27 | 36 | $792.00 | $318.24 | 40.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 20 | 24 | $744.00 | $314.88 | 42.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 25 | 30 | $930.00 | $310.50 | 33.4% |
| 83525 | Insulin measurement, total | Office | 2023 | 21 | 25 | $675.00 | $280.00 | 41.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 27 | 34 | $782.00 | $258.74 | 33.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 14 | 16 | $432.00 | $213.76 | 49.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 26 | $8,127 | $1,860 | 22.9% |
About Marlene Dabestan, NP
Marlene Dabestan, NP is a Family healthcare provider based in Talent, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2022. The National Provider Identifier (NPI) number assigned to this provider is 1831828474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marlene Dabestan, NP has received a total of $382.05 in payments from pharmaceutical and medical device companies, with $257.72 received in 2024. These payments were reported across 17 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($382.05).
As a Medicare-enrolled provider, Dabestan has provided services to 468 Medicare beneficiaries, totaling 661 services with total Medicare billing of $16,389. Data is available for 2 years (2022–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Talent, OR
- Active Since 06/08/2022
- Last Updated 09/03/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1831828474
Products in Payments
- Cologuard Collection Kit (Device) $112.58
- QULIPTA (Drug) $74.40
- TRINTELLIX (Drug) $48.32
- Veozah (Drug) $39.57
- Wegovy (Drug) $33.79
- UBRELVY (Drug) $29.50
- CREON (Drug) $22.35
- REXULTI (Drug) $21.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.